Business News • MarketWire • Correction: Immunovative, Inc. Announces Collaboration With The Robert H. Lurie Compehensive Cancer Center of Northwestern University

Correction: Immunovative, Inc. Announces Collaboration With The Robert H. Lurie Compehensive Cancer Center of Northwestern University

Correction: Immunovative, Inc. Announces Collaboration With The Robert H. Lurie Compehensive Cancer Center of Northwestern University

NEW YORK, NY--(Marketwire - Oct 6, 2012) - Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) announces today that Immunovative Therapies, Ltd. ("ITL") and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University ("Lurie Cancer Center") have agreed to collaborate on the clinical development of its two lead immunotherapy drugs, AlloStimT and AlloVaxT ("Study Drugs").

View More : http://www.marketwire.com/mw/release.do?id=1709954&sourceType=3

Releted News by marketwire

Disposition of Common Shares of EcoSynthetix Inc.

RAPPEL : BMO invite à soutenir les agriculteurs canadiens à l'occasion de la fête de l'Action de grâce

REPEAT-BMO: Support Canadian Farmers This Thanksgiving